STATERA BIOPHARMA
Statera BioPharma is a biotechnology research agency that provides biotechnology research services. The company was founded in 2014 and is headquartered in Fort Collins, Colorado, United States.
STATERA BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Fort Collins, Colorado, United States
Country:
United States
Website Url:
http://www.staterabiopharma.com
Total Employee:
11+
Status:
Active
Contact:
888-613-8802
Total Funding:
26.14 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon HSTS ReCAPTCHA Person Schema Facebook Sharer Gravatar Profiles Apple Mobile Web App Capable ReCAPTCHA V2 Amazon Virginia Region
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Pioneering Medicines
Pioneering Medicines is a biotechnology research agency providing biotechnology to life sciences services.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Official Site Inspections
http://www.staterabiopharma.com Semrush global rank: 6.34 M Semrush visits lastest month: 1.05 K
- Host name: box5938.bluehost.com
- IP address: 96.125.174.28
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092

More informations about "Statera BioPharma"
Statera BioPharma - Wikipedia
Statera BioPharma, Inc. is an American clinical-stage biopharmaceutical company with a focus on novel immunotherapies. In 2021, Cleveland BioLabs merged with Cytocom, Inc, a clinical โฆSee details»
Statera BioPharma, Inc. | LinkedIn
Statera BioPharma, Inc. | 1,038 followers on LinkedIn. Restoring Immune Health | Statera Biopharmaโs foundation is based on restoring immune health through the leveraging of โฆSee details»
STAB - Statera Biopharma, Inc. | Company Profile | OTC Markets
Www.staterabiopharma.com (888) 613-8802. [email protected]. Business Description. Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical โฆSee details»
Statera BioPharma - Crunchbase Company Profile & Funding
Statera BioPharma is a biotechnology research agency that provides biotechnology research services. The company was founded in 2014 and is headquartered in Fort Collins, Colorado, โฆSee details»
Statera Biopharma, Inc. (STAB) - Yahoo Finance
See the company profile for Statera Biopharma, Inc. (STAB) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Statera Biopharma - Craft
Oct 29, 2024 Fort Collins, CO HQ. United States. 4333 Corbett Dr #1082. Fort Collins, CO. United States. 2537 Research Blvd Suite 201See details»
Statera Biopharma (STAB) Company Profile & Description - Stock โฆ
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers โฆSee details»
Home: Statera Biopharma, Inc. - Statera Biopharma: Restoring โฆ
Restoring Immune Health Statera Biopharma's foundation is based on restoring immune health through the leveraging of complex pleiotropic beneficial effects. Read The Story STAT-200: โฆSee details»
Statera Biopharma Company Profile | Management and Employees โฆ
[email protected]: 4: first_last: [email protected]: 5: last: [email protected]: Your Questions, Our Answers Get Free Access to Statera โฆSee details»
October 2021 Corporate Presentation - Statera Biopharma
Immunology research organization to define additional mechanism of actions (MOAs) of platform HISTORY. October 2021 4 Statera Biopharma intends to become the leader in developing and โฆSee details»
Subsidiaries & Partners - Statera Biopharma: Restoring Immune โฆ
Incuronโs clinical lead curaxin CBL0137, demonstrated significant anti-cancer activity in a number of preclinical tumor models, including colon, pancreatic, prostate and breast adenocarcinomas, โฆSee details»
News - Statera Biopharma: Restoring Immune Health
Oct 6, 2021 FORT COLLINS, Colo., Sept. 2, 2021 /PRNewswire/ -- Statera BioPharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune โฆSee details»
staterabiopharma.com Reviews: Is this site a scam or legit?
After you read why we gave staterabiopharma.com this trust score, please share how you came across this platform in the comments below.. Scam Detectors Most Trusted Websites in Online โฆSee details»
Statera Biopharma - VentureRadar
Statera Biopharma, Inc. (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune,... ... Find out ...See details»
Statera BioPharma, Inc. Overview | SignalHire Company Profile
Statera BioPharma, Inc. headquarters is in Fort Collins, Colorado. Statera BioPharma, Inc. is in the sectors of: Biotech. To connect with Statera BioPharma, Inc.'s employee register on โฆSee details»
Statera Biopharma - Overview, News & Similar companies
Jan 30, 2023 Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs FORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. โฆSee details»
Statera Biopharma and Immune Therapeutics Inc. Announce
Apr 27, 2022 To learn more about Statera Biopharma, please visit www.staterabiopharma.com. About Immune Therapeutics . Immune Therapeutics is a specialty pharmaceutical company โฆSee details»
Our Science - Statera Biopharma: Restoring Immune Health
STAT-600 Oncology and Hematology: The STAT-600 program looks to leverage the data obtained from numerous trials and studies conducted with TLR5 variants over the years, โฆSee details»
Enara Bio Strengthens Senior Leadership with Key Executive and โฆ
4 days ago Oxford, United Kingdom โ May 01, 2025.Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and โฆSee details»
For Patients - Statera Biopharma: Restoring Immune Health
COVID-19 This is an exploratory, randomized, placebo controlled, multi-center study to assess the pharmacokinetics and biomarkers of STAT-201 as a potential treatment to slow or halt the โฆSee details»